Abstract
The majority of melanocytic neoplasms can be correctly diagnosed using routine histopathologic analysis. However, a significant minority of tumors have ambiguous histopathologic attributes that overlap between melanocytic nevi and melanoma. Ancillary tests that assist in distinguishing potentially lethal melanomas from benign melanocytic nevi with atypical histopathologic features are available, but still need refining.
Most melanomas have chromosomal copy number aberrations, frequently involving multiple chromosomes. With rare exceptions, such anomalies are not found in melanocytic nevi. This difference formed the basis to develop assays that can help distinguish melanoma from nevi by fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). FISH can detect chromosomal copy number changes of a limited number of loci within individual cells. By contrast, CGH assesses copy number across the entire genome, but typically is performed on bulk cell populations so that copy number changes in individual cells or subpopulations of cells can go undetected. Both FISH and CGH have been used to provide genomic information in histopathologically ambiguous melanocytic tumors that can assist pathologists make correct diagnoses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balaban GB, Herlyn M, Clark WH Jr, Nowell PC (1986) Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet 19(1–2):113–122
Cowan JM, Halaban R, Francke U (1988) Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 80(14):1159–1164
Hecht F, Hecht BK (1988) Chromosome rearrangements in dysplastic nevus syndrome predisposing to malignant melanoma. Cancer Genet Cytogenet 35(1):73–78
Richmond A, Fine R, Murray D, Lawson DH, Priest JH (1986) Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 86(3):295–302
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258(5083):818–821
Speicher MR, Prescher G, du Manoir S, Jauch A, Horsthemke B, Bornfeld N, Becher R, Cremer T (1994) Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 54(14):3817–3823
Ghazvini S, Char DH, Kroll S, Waldman FM, Pinkel D (1996) Comparative genomic hybridization analysis of archival formalin-fixed paraffin-embedded uveal melanomas. Cancer Genet Cytogenet 90(2):95–101
Bastian BC, LeBoit PE, Hamm H, Bröcker E-B, Pinkel D (1998) Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58(10):2170–2175
Bastian BC, Olshen AB, LeBoit PE, Pinkel D (2003) Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163(5):1765–1770
Balázs M, Adám Z, Treszl A, Bégány A, Hunyadi J, Adány R (2001) Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 46(4):222–232
Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D, Albertson DG (2001) Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29(3):263–264
Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, Laine E, Greulich H, Tseng H, Gates C, Hodi FS, Dranoff G, Sellers WR, Thomas RK, Meyerson M, Golub TR, Dummer R, Herlyn M, Getz G, Garraway LA (2008) Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 68(3):664–673
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho K-H, Aiba S, Bröcker E-B, LeBoit PE, Pinkel D, Bastian BC (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353(20):2135–2147
Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH 2nd, Bröcker EB, LeBoit PE, Pinkel D (2000) Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60(7):1968–1973
North JP, Kageshita T, Pinkel D, LeBoit PE, Bastian BC (2008) Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol 128(8):2024–2030
van Dijk M, Sprenger S, Rombout P, Marres H, Kaanders J, Jeuken J, Ruiter D (2003) Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization. Genes Chromosomes Cancer 36(2):151–158
Maize JC Jr, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC (2005) Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol 29(9):1214–1220
Busam KJ, Woodruff JM, Erlandson RA, Brady MS (2000) Large plaque-type blue nevus with subcutaneous cellular nodules. Am J Surg Pathol 24(1):92–99
Yeh I, Fang Y, Busam KJ (2012) Melanoma arising in a large plaque-type blue nevus with subcutaneous cellular nodules. Am J Surg Pathol 36(8):1258–1263
North JP, Yeh I, McCalmont TH, LeBoit PE (2012) Melanoma ex blue nevus: two cases resembling large plaque-type blue nevus with subcutaneous cellular nodules. J Cutan Pathol 39(12):1094–1099
Gerami P, Pouryazdanparast P, Vemula S, Bastian BC (2010) Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Am J Dermatopathol 32(3):301–305
Bastian BC, Wesselmann U, Pinkel D, Leboit PE (1999) Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113(6):1065–1069
Bastian BC, LeBoit PE, Pinkel D (2000) Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 157(3):967–972
Ali L, Helm T, Cheney R, Conroy J, Sait S, Guitart J, Gerami P (2010) Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms. Int J Clin Exp Pathol 3(6):593–599
Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H, Rees JL (1996) Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res 56(3):589–593
Raskin L, Ludgate M, Iyer RK, Ackley TE, Bradford CR, Johnson TM, Fullen DR (2011) Copy number variations and clinical outcome in atypical spitz tumors. Am J Surg Pathol 35(2):243–252
Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rütten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43(10):1018–1021
Busam KJ, Sung J, Wiesner T, von Deimling A, Jungbluth A (2013) Combined BRAFV600E-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes. Am J Surg Pathol 37:193–199
Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S (2001) Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 42(2):313–317
White JS, McLean IW, Becker RL, Director-Myska AE, Nath J (2006) Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival. Cancer Genet Cytogenet 170(1):29–39
Mensink HW, Kiliç E, Vaarwater J, Douben H, Paridaens D, de Klein A (2008) Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet 181(2):108–111
Trolet J, Hupé P, Huon I, Lebigot I, Decraene C, Delattre O, Sastre-Garau X, Saule S, Thiéry J-P, Plancher C, Asselain B, Desjardins L, Mariani P, Piperno-Neumann S, Barillot E, Couturier J (2009) Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci 50(6):2572–2580
Bastian BC, Xiong J, Frieden IJ, Williams ML, Chou P, Busam K, Pinkel D, LeBoit PE (2002) Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol 161(4):1163–1169
Adám Z, Adány R, Ladányi A, TÃmár J, Balázs M (2000) Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p. Clin Exp Metastasis 18(4):295–302
Günther K, Fleischer A, Buettner R, Bosserhoff AK (2001) Detection of invasion-related chromosomal changes in highly and weakly invasive melanoma cell clones by a modified comparative genomic hybridization approach. Melanoma Res 11(2):105–115
Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, Matushek P 4th, Legator M, Jacobson K, Dalton SR, Charzan S, Kolaitis NA, Guitart J, Lertsbarapa T, Boone S, LeBoit PE, Bastian BC (2009) Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 33(8):1146–1156
Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, Piris A, Mihm MC Jr (2009) A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions. Pathologica 101(5):169–174
Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA (2009) Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 41(4):383–387
Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P (2009) Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod Pathol 22(8):989–995
Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI (1995) Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 55(5):984–988
Becher R, Korn WM, Prescher G (1997) Use of fluorescence in situ hybridization and comparative genomic hybridization in the cytogenetic analysis of testicular germ cell tumors and uveal melanomas. Cancer Genet Cytogenet 93(1):22–28
Barks JH, Thompson FH, Taetle R, Yang JM, Stone JF, Wymer JA, Khavari R, Guan XY, Trent JM, Pinkel D, Nelson MA (1997) Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma. Genes Chromosomes Cancer 19(4):278–285
Guan XY, Zhang H, Yang JM, Wang J, Taetle R, Meltzer PS, Trent JM (1998) Detection of chromosome 6 abnormalities in melanoma cell lines by chromosome arm painting probes. Cancer Genet Cytogenet 107(2):89–92
Okamoto I, Pirc-Danoewinata H, Ackermann J, Drach J, Schlagbauer Wadl H, Jansen B, Wolff K, Pehamberger H, Marosi C (1999) Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization. Br J Cancer 79(1):131–137
Multani AS, Ozen M, Sen S, Mandal AK, Price JE, Fan D, Radinsky R, Ali-Osman F, Von Eschenbach AC, Fidler IJ, Pathak S (1999) Amplification of telomeric DNA directly correlates with metastatic potential of human and murine cancers of various histological origin. Int J Oncol 15(3):423–429
Kraehn GM, Utikal J, Udart M, Greulich KM, Bezold G, Kaskel P, Leiter U, Peter RU (2001) Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Br J Cancer 84(1):72–79
Rákosy Z, VÃzkeleti L, Ecsedi S, Vokó Z, Bégány A, Barok M, Krekk Z, Gallai M, Szentirmay Z, Adány R, Balázs M (2007) EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int J Cancer 121(8):1729–1737
Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC (2001) Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 84(4):535–538
Newman MD, Mirzabeigi M, Gerami P (2009) Chromosomal copy number changes supporting the classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma. Mod Pathol 22(9):1258–1262
Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P (2009) Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol 33(9):1396–1400
Gammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P (2011) Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J Cutan Pathol 38(4):335–341
Dalton SR, Gerami P, Kolaitis NA, Charzan S, Werling R, LeBoit PE, Bastian BC (2010) Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol 34(2):231–237
Busam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH (2010) Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J Cutan Pathol 37(2):196–203
Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ (2009) Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol 33(12):1783–1788
Gerami P, Barnhill RL, Beilfuss BA, LeBoit P, Schneider P, Guitart J (2010) Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH. Am J Surg Pathol 34(6):816–821
DÃaz A, Valera A, Carrera C, Hakim S, Aguilera P, GarcÃa A, Palou J, Puig S, Malvehy J, Alos L (2011) Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am J Surg Pathol 35(11):1733–1742
Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ (2011) Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol 38(4):329–334
Massi D, Cesinaro AM, Tomasini C, Paglierani M, Bettelli S, Dal Maso L, Simi L, Salvianti F, Pinzani P, Orlando C, De Giorgi V, Lukic S, Maiorana A, Santucci M, Canzonieri V (2011) Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol 64(5):919–935
Vergier B, Prochazkova-Carlotti M, de la Fouchardière A, Cerroni L, Massi D, De Giorgi V, Bailly C, Wesselmann U, Karlseladze A, Avril M-F, Jouary T, Merlio J-P (2011) Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol 24(5):613–623
Hung T, Piris A, Lobo A, Mihm MC Jr, Sober AJ, Tsao H, Tanabe KK, Duncan LM (2013) Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol 44:87–94
Cesinaro AM, Schirosi L, Bettelli S, Migaldi M, Maiorana A (2010) Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz’s nevi but do not predict their biological behaviour. Histopathology 57(4):515–527
Gammon B, Beilfuss B, Guitart J, Gerami P (2012) Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol 36(1):81–88
Gerami P, Li G, Pouryazdanparast P, Blondin B, Beilfuss B, Slenk C, Du J, Guitart J, Jewell S, Pestova K (2012) A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol 36(6):808–817
Ryan D, Rafferty M, Hegarty S, O’Leary P, Faller W, Gremel G, Bergqvist M, Agnarsdottir M, Strömberg S, Kampf C, Pontén F, Millikan RC, Dervan PA, Gallagher WM (2010) Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis. Pigment Cell Melanoma Res 23(4):542–553
North JP, Vetto JT, Murali R, White KP, White CR Jr, Bastian BC (2011) Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol 35(8):1146–1150
Gerami P, Jewell SS, Pouryazdanparast P, Wayne JD, Haghighat Z, Busam KJ, Rademaker A, Morrison L (2011) Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn 13(3):352–358
Pouryazdanparast P, Cowen DP, Beilfuss BA, Haghighat Z, Guitart J, Rademaker A, Gerami P (2012) Distinctive clinical and histologic features in cutaneous melanoma with copy number gains in 8q24. Am J Surg Pathol 36(2):253–264
Gammon B, Ali L, Guitart J, Gerami P (2012) Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma. Am J Dermatopathol 34(5):487–490
Isaac AK, Lertsburapa T, Pathria Mundi J, Martini M, Guitart J, Gerami P (2010) Polyploidy in spitz nevi: a not uncommon karyotypic abnormality identifiable by fluorescence in situ hybridization. Am J Dermatopathol 32(2):144–148
Pouryazdanparast P, Haghighat Z, Beilfuss BA, Guitart J, Gerami P (2011) Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings. Am J Surg Pathol 35(9):1405–1412
Satoh S, Hashimoto-Tamaoki T, Furuyama J, Mihara K, Namba M, Kitano Y (2000) High frequency of tetraploidy detected in malignant melanoma of Japanese patients by fluorescence in situ hybridization. Int J Oncol 17(4):707–715
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
North, J.P., Vemula, S.S., Bastian, B.C. (2014). Chromosomal Copy Number Analysis in Melanoma Diagnostics. In: Thurin, M., Marincola, F. (eds) Molecular Diagnostics for Melanoma. Methods in Molecular Biology, vol 1102. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-727-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-727-3_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-726-6
Online ISBN: 978-1-62703-727-3
eBook Packages: Springer Protocols